Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2025-07-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Inspiratory Muscle Training in Patients With Parkinson's Disease
NCT06017336
Effects of Inspiratory Muscle Training in Patients With Parkinson's Disease
NCT04228887
The Effects of Respiratory Muscle Strength in Parkinson Disease
NCT04042675
Effects of Walking and Respiratory Muscle Training on Pulmonary Function and Functional Exercise Capacity in PD
NCT04834258
The Ultrasonographic Evaluation of Abdominal Accessory Respiratory Muscle Thickness in Patients With Parkinson's Disease: Correlation With Disease Severity and Expiratory Respiratory Muscle Strength
NCT07308795
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Stage Patients with Parkinson's Disease
According to the Modified Hoehn and Yahr Scale (MHÖ), patients with a score below 2.5
No interventions assigned to this group
Advanced Stage Patients with Parkinson's Disease
According to the Modified Hoehn and Yahr Scale (MHÖ), patients with 2.5 and above
No interventions assigned to this group
Control Group
Healthy individuals with similar demographic characteristics
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mini Mental State Examination score of 24 to 30
* Diagnosed with Parkinson's Disease by a neurologist
Exclusion Criteria
* Yürüme yardımcısı kullanıma
* Ciddi görme bozukluğu, ek nörolojik bozuklukları ve/veya konjestif kalp yetmezliği olan yaşlılar
* Egzersiz yapılması tavsiye edilmeyen yaşlı yetişkinler.
50 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Atılım University
OTHER
Ankara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Büşra Seçkinoğulları Korkusuz
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Süleyman Korkusuz, PhD
Role: STUDY_CHAIR
Atılım University
Ayla Fil Balkan, Assoc Prof
Role: STUDY_CHAIR
Hacettepe University
Gül Yalçın Çakmaklı, Assoc Prof
Role: STUDY_CHAIR
Hacettepe University
Neslihan Durutürk, Prof.Dr
Role: STUDY_CHAIR
Baskent University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Atılım University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Shill H, Stacy M. Respiratory function in Parkinson's disease. Clin Neurosci. 1998;5(2):131-5.
Morris ME, Iansek R, Matyas TA, Summers JJ. Ability to modulate walking cadence remains intact in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1532-4. doi: 10.1136/jnnp.57.12.1532.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-59394181-604.01-112206
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.